Background As transcatheter aortic valve replacement (TAVR) technology expands to
healthy and lower‐risk populations, the burden and predictors of procedure‐related …

Objectives Patients undergoing surgery for severe aortic stenosis (SAS) can be treated with
either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement …

Aortic valve stenosis (AS) is the most common valvular pathology and has traditionally been
managed using surgical aortic valve replacement (SAVR). A large proportion of affected …

Background The treatment of aortic stenosis is evolving rapidly. Pace of change in the care
of patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic …

Introduction The establishment of transcatheter aortic valve implantation (TAVI) has
revolutionized the treatment of severe aortic stenosis. However, with TAVI being approved …

Abstract 3D printing technologies have the potential to revolutionize the manufacture of
heart valves through the ability to create bespoke, complex constructs. In light of recent …

Background Aortic stenosis (AS) is a common cardiac condition whose prevalence
increases with age. The symptom burden associated with severe aortic stenosis (AS) can …

Aims To evaluate the patient-and procedure-related predictors of transcatheter aortic-valve
implantation (TAVI)-associated ischemic brain lesions and to assess the effect of silent …

Background Patients with severe aortic stenosis who have comorbidities that prevent
general anesthesia and open cardiothoracic surgery are candidates for transcatheter aortic …

Beyond thromboembolic events, peri-procedural bleeding remains one of the most frequent
complications after transcatheter aortic valve implantation (TAVI). The majority of TAVI …